Privia Health Net Worth

Privia Health Net Worth Breakdown

  PRVA
The net worth of Privia Health Group is the difference between its total assets and liabilities. Privia Health's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Privia Health's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Privia Health's net worth can be used as a measure of its financial health and stability which can help investors to decide if Privia Health is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Privia Health Group stock.

Privia Health Net Worth Analysis

Privia Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Privia Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Privia Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Privia Health's net worth analysis. One common approach is to calculate Privia Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Privia Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Privia Health's net worth. This approach calculates the present value of Privia Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Privia Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Privia Health's net worth. This involves comparing Privia Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Privia Health's net worth relative to its peers.

Enterprise Value

2.43 Billion

To determine if Privia Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Privia Health's net worth research are outlined below:
Privia Health Group generated a negative expected return over the last 90 days
Privia Health Group is unlikely to experience financial distress in the next 2 years
Privia Health Group has a strong financial position based on the latest SEC filings
Over 93.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

Privia Health Quarterly Good Will

141.62 Million

Privia Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Privia Health Group. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Privia Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Privia Health's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Privia Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Privia Health Group backward and forwards among themselves. Privia Health's institutional investor refers to the entity that pools money to purchase Privia Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of New York Mellon Corp2025-03-31
2.2 M
Van Berkom And Associates Inc2025-03-31
M
Wellington Management Company Llp2025-03-31
1.9 M
Dimensional Fund Advisors, Inc.2025-03-31
1.7 M
Nuveen Asset Management, Llc2024-12-31
1.5 M
Northern Trust Corp2025-03-31
1.4 M
Loomis, Sayles & Company Lp2025-03-31
1.4 M
Franklin Resources Inc2025-03-31
1.3 M
Nuveen, Llc2025-03-31
1.2 M
Blackrock Inc2025-03-31
18.3 M
Fmr Inc2025-03-31
18 M
Note, although Privia Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Privia Health's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.52 B.

Market Cap

2.84 Billion

Project Privia Health's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.02  0.03 
Return On Assets 0.01  0.01 
Return On Equity 0.02  0.02 
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.
When accessing Privia Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Privia Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Privia Health's profitability and make more informed investment decisions.
Please note, the presentation of Privia Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Privia Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Privia Health's management manipulating its earnings.

Evaluate Privia Health's management efficiency

Privia Health Group has return on total asset (ROA) of 0.0121 % which means that it generated a profit of $0.0121 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0301 %, meaning that it created $0.0301 on every $100 dollars invested by stockholders. Privia Health's management efficiency ratios could be used to measure how well Privia Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.02. The current year's Return On Capital Employed is expected to grow to 0.03. At present, Privia Health's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 54.4 M, whereas Total Assets are forecasted to decline to about 701.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 5.72  6.01 
Tangible Book Value Per Share 3.62  3.80 
Enterprise Value Over EBITDA 76.24  152.00 
Price Book Value Ratio 3.68  3.49 
Enterprise Value Multiple 76.24  152.00 
Price Fair Value 3.68  3.49 
Enterprise Value1.8 B2.4 B
The leadership approach at Privia Health's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue
1.1395
Revenue
1.8 B
Quarterly Revenue Growth
0.156
Revenue Per Share
15.019
Return On Equity
0.0301
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Privia Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Privia Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Privia Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Matthew Morris over a month ago
Acquisition by Matthew Morris of 8396 shares of Privia Health subject to Rule 16b-3
 
Thomas Bartrum over a month ago
Acquisition by Thomas Bartrum of 15000 shares of Privia Health at 2.0 subject to Rule 16b-3
 
Mountcastle David over two months ago
Disposition of 3322 shares by Mountcastle David of Privia Health at 24.99 subject to Rule 16b-3
 
Parth Mehrotra over two months ago
Disposition of 15100 shares by Parth Mehrotra of Privia Health at 23.33 subject to Rule 16b-3
 
Mountcastle David over three months ago
Disposition of 100000 shares by Mountcastle David of Privia Health at 25.15 subject to Rule 16b-3
 
Fargis Edward C over three months ago
Disposition of 2438 shares by Fargis Edward C of Privia Health at 23.88 subject to Rule 16b-3
 
Fargis Edward C over three months ago
Disposition of 2529 shares by Fargis Edward C of Privia Health at 24.53 subject to Rule 16b-3
 
Matthew Morris over three months ago
Disposition of 89318 shares by Matthew Morris of Privia Health at 23.0 subject to Rule 16b-3
 
Parth Mehrotra over three months ago
Acquisition by Parth Mehrotra of 133723 shares of Privia Health subject to Rule 16b-3
 
Matthew Morris over six months ago
Disposition of 154676 shares by Matthew Morris of Privia Health at 2.0 subject to Rule 16b-3
 
Parth Mehrotra over six months ago
Disposition of 12414 shares by Parth Mehrotra of Privia Health at 2.0 subject to Rule 16b-3
 
Mountcastle David over six months ago
Disposition of 2320 shares by Mountcastle David of Privia Health at 18.42 subject to Rule 16b-3

Privia Health Corporate Filings

F3
17th of July 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
8th of July 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
23rd of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
12th of May 2025
Other Reports
ViewVerify
Privia Health time-series forecasting models is one of many Privia Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Privia Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Privia Health Earnings per Share Projection vs Actual

Privia Health Corporate Management

Dana CPASenior OfficerProfile
Chris VoigtExecutive OfficerProfile
Jim MDCEO TennesseeProfile
Thomas BartrumExecutive CounselProfile
Robert BorchertSenior CommunicationsProfile
Jay StevensSenior OfficerProfile
When determining whether Privia Health Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Privia Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Privia Health Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Privia Health Group Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Privia Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Privia Health. If investors know Privia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Privia Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.5
Earnings Share
0.12
Revenue Per Share
15.019
Quarterly Revenue Growth
0.156
Return On Assets
0.0121
The market value of Privia Health Group is measured differently than its book value, which is the value of Privia that is recorded on the company's balance sheet. Investors also form their own opinion of Privia Health's value that differs from its market value or its book value, called intrinsic value, which is Privia Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Privia Health's market value can be influenced by many factors that don't directly affect Privia Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Privia Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Privia Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Privia Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.